Riverwater Partners LLC Haemonetics Corp Transaction History
Riverwater Partners LLC
- $177 Million
- Q4 2024
A detailed history of Riverwater Partners LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Riverwater Partners LLC holds 50,379 shares of HAE stock, worth $3.17 Million. This represents 2.22% of its overall portfolio holdings.
Number of Shares
50,379
Previous 44,841
12.35%
Holding current value
$3.17 Million
Previous $3.6 Million
9.16%
% of portfolio
2.22%
Previous 1.99%
Shares
9 transactions
Others Institutions Holding HAE
# of Institutions
349Shares Held
55.7MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$376 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$326 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$279 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$267 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$248 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.23B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...